CJC-1295 (No DAC) 9mg + Ipamorelin 9mg

CJC-1295 (No DAC) and Ipamorelin are investigational peptides that have been studied in relation to the growth-hormone (GH) signalling pathway. CJC-1295 (No DAC) is a growth-hormone-releasing hormone analogue, while Ipamorelin is a growth-hormone secretagogue that acts through the ghrelin receptor pathway.

Research areas include: GH and IGF-1 signalling, endocrine research, pituitary hormone regulation, metabolic signalling and growth-hormone pathway research. However, CJC-1295 (No DAC) has very limited direct human evidence, and the specific CJC-1295 (No DAC) + Ipamorelin combination shown here has not been established through a published clinical trial.

Important: CJC-1295 (No DAC) and Ipamorelin are not approved medicines for general human use. The specific 18mg pre-filled pen formulation shown here has not been established as an approved pharmaceutical product. This product is provided for research purposes only and is not intended to diagnose, treat, cure or prevent any disease or medical condition.

The Certificate of Analysis for lot GX-2026 confirms an HPLC purity of 99%+ and identity confirmed by mass spectrometry.

The Safety Data Sheet describes handling, storage and disposal information for this research compound. Always follow standard laboratory safety practice.